Literature DB >> 21832957

Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantation.

Silas P Norman1, Mallika Kommareddi, Akinlolu O Ojo, Fu L Luan.   

Abstract

BACKGROUND: Early pancreas graft failure after simultaneous pancreas and kidney (SPK) transplantation is common. We studied the impact of early pancreas graft failure on long-term kidney and patient survival.
METHODS: We included all primary SPK transplants performed in the United States between January 1, 2000, and December 31, 2007, who had maintained kidney graft function at 90 days posttransplantation. Kaplan-Meier and Cox multivariate analyses were performed. The causes of death between the two cohorts were compared.
RESULTS: A total of 6282 SPK recipients were included in the analyses. Of those, 470 had lost pancreas graft within the first 90 days largely related to pancreas graft thrombosis. Early pancreas graft failure was associated with lower subsequent kidney graft and patient survival (log-rank, P=0.02 and P<0.001, respectively). Multivariate regression analyses demonstrated a 70% higher risk of kidney graft failure after 3 years (adjusted hazard ratio 1.69; 95% CI 1.08, 2.66; P=0.022) and more than doubled the risk for death (adjusted hazard ratio 2.18; 95% CI 1.67, 2.85; P<0.001) among SPK recipients with early pancreas graft failure. The causes of death were similar between the two cohorts.
CONCLUSION: Early pancreas graft failure in SPK transplant recipients is associated with an increased risk for subsequent kidney failure and death. Optimization of therapeutic interventions after early pancreas graft failure is needed.

Entities:  

Mesh:

Year:  2011        PMID: 21832957      PMCID: PMC3831506          DOI: 10.1097/TP.0b013e31822dc36b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  23 in total

1.  Difference in estimated GFR with two different formulas in elderly individuals.

Authors:  K Wieczorowska-Tobis; Z I Niemir; P Guzik; A Breborowicz; D G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  Disposition and regulation of body potassium: an overview.

Authors:  W N Suki
Journal:  Am J Med Sci       Date:  1976 Jul-Aug       Impact factor: 2.378

3.  Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.

Authors:  S A Atlas; D B Case; J E Sealey; J H Laragh; D N McKinstry
Journal:  Hypertension       Date:  1979 May-Jun       Impact factor: 10.190

4.  Hyperkalemia in azotemic patients during angiotensin-converting enzyme inhibition and aldosterone reduction with captopril.

Authors:  S C Textor; E L Bravo; F M Fouad; R C Tarazi
Journal:  Am J Med       Date:  1982-11       Impact factor: 4.965

5.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

6.  Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Authors:  T H Jafar; C H Schmid; M Landa; I Giatras; R Toto; G Remuzzi; G Maschio; B M Brenner; A Kamper; P Zucchelli; G Becker; A Himmelmann; K Bannister; P Landais; S Shahinfar; P E de Jong; D de Zeeuw; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  2001-07-17       Impact factor: 25.391

7.  Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Authors:  G L Bakris; M R Weir
Journal:  Arch Intern Med       Date:  2000-03-13

8.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.

Authors:  L Y Agodoa; L Appel; G L Bakris; G Beck; J Bourgoignie; J P Briggs; J Charleston; D Cheek; W Cleveland; J G Douglas; M Douglas; D Dowie; M Faulkner; A Gabriel; J Gassman; T Greene; Y Hall; L Hebert; L Hiremath; K Jamerson; C J Johnson; J Kopple; J Kusek; J Lash; J Lea; J B Lewis; M Lipkowitz; S Massry; J Middleton; E R Miller; K Norris; D O'Connor; A Ojo; R A Phillips; V Pogue; M Rahman; O S Randall; S Rostand; G Schulman; W Smith; D Thornley-Brown; C C Tisher; R D Toto; J T Wright; S Xu
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

Review 9.  Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues.

Authors:  Amy J Mangrum; George L Bakris
Journal:  Semin Nephrol       Date:  2004-03       Impact factor: 5.299

Review 10.  Hyperkalemia: An adaptive response in chronic renal insufficiency.

Authors:  F John Gennari; Alan S Segal
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  7 in total

1.  Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement.

Authors:  Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski
Journal:  Transplantation       Date:  2016-02       Impact factor: 4.939

2.  Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease.

Authors:  J P Lindahl; A Hartmann; R Horneland; H Holdaas; A V Reisæter; K Midtvedt; T Leivestad; O Oyen; T Jenssen
Journal:  Diabetologia       Date:  2013-04-03       Impact factor: 10.122

3.  A composite risk model for predicting technical failure in pancreas transplantation.

Authors:  E B Finger; D M Radosevich; T B Dunn; S Chinnakotla; D E R Sutherland; A J Matas; T L Pruett; R Kandaswamy
Journal:  Am J Transplant       Date:  2013-05-24       Impact factor: 8.086

4.  Survival After Simultaneous Pancreas-Kidney Transplantation in Type 1 Diabetes: The Critical Role of Early Pancreas Allograft Function.

Authors:  Mengmeng Ji; Mei Wang; Wenjun Hu; Mohamed Ibrahim; Krista Lentine; Massini Merzkani; Haris Murad; Yazen Al-Hosni; Ronald Parsons; Jason Wellen; Su-Hsin Chang; Tarek Alhamad
Journal:  Transpl Int       Date:  2022-09-12       Impact factor: 3.842

5.  A Reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.

Authors:  Randall S Sung; Min Zhang; Douglas E Schaubel; Xu Shu; John C Magee
Journal:  Transplantation       Date:  2015-09       Impact factor: 4.939

Review 6.  Kidney Transplantation in the Diabetic Patient.

Authors:  María José Pérez-Sáez; Julio Pascual
Journal:  J Clin Med       Date:  2015-06-09       Impact factor: 4.241

Review 7.  Simultaneous Pancreas-Kidney Transplantation Versus Living Donor Kidney Transplantation Alone: an Outcome-Driven Choice?

Authors:  Vishnu Swaroop Venkatanarasimhamoorthy; Adam D Barlow
Journal:  Curr Diab Rep       Date:  2018-07-20       Impact factor: 4.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.